Shibing Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Top Venues

Cancer management and research

OncoTargets and therapy

Molecular biology reports

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Shibing Wang, Xue Yang, Ying-Yu Ma, Junjie Wu, Ke-Tao Jin, Ruibo Zhao, Hai Zou, Xiao-Zhou Mou
An engineered self-biomineralized oncolytic adenovirus induces effective antitumor immunity and synergizes with immune checkpoint blockade. Cancer immunology research (2024)
Jiaying Lou, Jialin Dong, Ruijun Xu, Hui Zeng, Lijuan Fang, Yi Wu, Yang Liu, Shibing Wang
Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes. Bioscience reports 41 (6) (2022)
Wen Lei, Qian Ye, Yuanyuan Hao, Jie Chen, Yu Huang, Liu Yang, Shibing Wang, Weidong Han
CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma. Blood cancer journal 12 (2) (2022)
Nanni Hua, Anxian Chen, Chen Yang, Hui Dong, Xianglei He, Guoqing Ru, Xiangmin Tong, Feifei Zhou, Shibing Wang
The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma. Molecular biology reports 49 (8) (2022)
Gang Cheng, Hui Dong, Chen Yang, Yang Liu, Yi Wu, Lifen Zhu, Xiangmin Tong, Shibing Wang
A review on the advances and challenges of immunotherapy for head and neck cancer. Cancer cell international 21 (1) (2021)
Lifen Zhu, Shufang Xie, Chen Yang, Nanni Hua, Yi Wu, Lei Wang, Wanmao Ni, Xiangmin Tong, Min Fei, Shibing Wang
Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS). Cancer management and research 13 (2021)
Peng Wang, Yi Wu, Chen Yang, Guanan Zhao, Yonghua Liu, Gang Cheng, Shibing Wang
Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma. OncoTargets and therapy 13 (2020)